Latest news with #MPHC
Qatar Tribune
5 days ago
- Business
- Qatar Tribune
MPHC posts QR379 mn in net profit for H1-2025
Tribune News Network Doha Mesaieed Petrochemical Holding Company (MPHC) reported a net profit of QR379 million for the six months ended 30 June 2025, down slightly from the same period last year, as global petrochemical markets faced persistent pricing and demand pressures. The Board of Directors approved an interim cash dividend of QR0.026 per share, representing 85% of net income for the period and totalling approximately QR327 million. Shareholders of record as of the close of trading on 20 August 2025 will be eligible to receive the payout, which will be processed by Edaa in accordance with applicable regulations. Group revenue for H1-2025 stood at QR1.4 billion, with earnings per share at QR0.030. While sales volumes increased compared with the first half of 2024, lower average selling prices weighed on overall revenue and profitability. EBITDA recorded a marginal decline in line with reduced top-line performance, with margins narrowing due to the drop in commodity prices across both the petrochemical and chlor-alkali segments. The first half of 2025 was marked by weak global demand for ethylene, derivatives, and other petrochemicals amid subdued industrial activity and cautious consumer spending. A surge in global production capacity exacerbated oversupply, lowering utilisation rates and intensifying competition. Price volatility—driven by fluctuating feedstock and energy costs, particularly crude oil—added uncertainty for naphtha-based producers. Regulatory compliance pressures and geopolitical risks further challenged operators, particularly those with ageing assets. Commodity prices across MPHC's portfolio continued the downward trajectory seen earlier in the year, reversing the elevated levels of the past two years. Softer demand, increased supply from new capacity additions, and macroeconomic uncertainty led to margin compression and more cautious purchasing behaviour. Despite the challenging market backdrop, MPHC maintained strong and adaptive operations. Production volumes improved year-on-year, supported by enhanced plant reliability and operational efficiencies. Quarter-on-quarter, output increased, particularly in the petrochemical segment, leading to higher sales volumes. The improved selling prices in this segment offset weaker performance in the chlor-alkali segment, which was hit by subdued demand for products such as EDC and VCM due to a slowdown in construction and industrial activity, along with high global inventories. MPHC closed the period with QR3.2 billion in cash and bank balances, reflecting a robust liquidity position. The decline from previous levels was mainly due to the distribution of the 2024 final dividend and funding for the Group's PVC project, partially offset by strong cash flow generation during the period. Management remains focused on operational efficiency and cost optimisation to mitigate the impact of global market challenges. The Group will also continue its investment in strategic projects, including the PVC plant, to diversify its portfolio and enhance long-term growth prospects. MPHC will host an investor relations earnings call on 18 August 2025 at 1:30 p.m. Doha time to discuss its results, business outlook, and other matters. The accompanying investor presentation will be available on the company's website under the 'financial information' section.
The Sun
05-08-2025
- Business
- The Sun
Malaysia sets sights on becoming Asean pharmaceutical and healthcare hub
KUALA LUMPUR: Malaysia is setting its sights on becoming a halal pharmaceutical and healthcare hub for Asean, leveraging partnerships with India's booming pharma sector as industry leaders prepare for the Second Malaysia Pharma and Healthcare Expo (MPHC 2025) in October. The expo, to be held at the World Trade Centre Kuala Lumpur from Oct 7 to 9, is expected to attract over 100 companies, up from 70 last year, alongside policymakers, researchers and investors across Asean, India, Australia and South Korea. Organisers say the event will spotlight innovations in halal-certified drugs, active pharmaceutical ingredients (APIs), biotech, regenerative medicine, telehealth and AI-driven diagnostics. Malaysia-India Business Council general secretary Datuk Surendran Menon said trade between Malaysia and India stood at US$20 billion (RM84.6 billion) in 2024, but pharmaceuticals made up just US$96–$104 million of that figure, a sign of significant untapped potential. 'India is known as the pharma of the world, while Malaysia offers halal regulation expertise and a strategic Asean strong potential in contract manufacturing, technology transfer and joint R&D, especially in halal pharmaceuticals and vaccines,' Surendran told reporters at a media briefing today. He said Malaysia imports over 70% of its pharmaceutical products, and the government's national pharmaceutical policy is pushing for greater domestic production, a move that could entice Indian firms seeking to expand into Asean markets. He also pointed to India's own 200 million-strong Muslim population as an untapped market for halal pharma products manufactured in Malaysia. 'Even if we tap just 50 million of that halal market in India, it's far larger than our domestic market here. Halal-certified medicines made in Malaysia could be exported not just across Asean but also back into India itself,' he said. This strategy, he added, would allow two-way investment flows, Indian companies bringing R&D and cost efficiencies to Malaysia, while Malaysian firms could set up manufacturing or joint ventures in India. Asean-India Economic Council chairman Datuk Ramesh Kodammal said Malaysia stands to benefit from India's US$50 billion pharmaceutical export industry, particularly as Asean and India review their free trade agreement, which has been in place for 11 years. 'If we work closely with India, we will have a lot of benefit,' he said, adding Malaysia has a great advantage of re-exporting with these Indian companies for the Asean market a huge market of 700 million people. Ramesh confirmed 40 Indian companies are slated to participate in MPHC 2025, alongside Asean, Australian and South Korean firms.
Zawya
04-07-2025
- Business
- Zawya
MPHC restructures partnership for salt production facility in Qatar
DOHA: Mesaieed Petrochemical Holding Company (MPHC) is pleased to announce a significant update following our previous announcement on 23rd September 2024. The parties has reached a mutual agreement for the exit of the Turkish partner 'Atlas' from the Memorandum of Understanding ('MoU') concerning the development and operation of a state-of-the-art salt production facility. The innovative salt production facility will now be established through a new joint venture ownership structure: Mesaieed Petrochemical Holding Company (MPHC): 60% equity stake, Qatar Industrial Manufacturing Co (QIMC): 40% equity stake This restructuring marks a pivotal step in advancing the project, ensuring streamlined operations and enhanced collaboration between the remaining partners. The facility aims to leverage cutting-edge technology to meet growing demand and contribute to Qatar's industrial diversification efforts. QAPCO remains the project development manager, providing all project-related support. Further details regarding the project will be disclosed in due course, upon reaching the (FID) stage. © Dar Al Sharq Press, Printing and Distribution. All Rights Reserved. Provided by SyndiGate Media Inc. (
Qatar Tribune
03-07-2025
- Business
- Qatar Tribune
MPHC restructures partnership for salt production facility in Qatar
Tribune News Network Doha Mesaieed Petrochemical Holding Company (MPHC) has announced a major restructuring in the partnership framework for its upcoming state-of-the-art salt production facility in Qatar. This development comes as a follow-up to the company's earlier announcement made on September 23, 2024. In a mutual agreement, the Turkish partner Atlas has exited the Memorandum of Understanding (MoU) that was initially signed for the development and operation of the facility. With this exit, the project will now move forward under a revised joint venture ownership structure comprising MPHC and Qatar Industrial Manufacturing Company (QIMC). Under the new arrangement, MPHC will hold a 60 percent equity stake while QIMC will own the remaining 40 percent. The restructuring represents a significant milestone in the project's progression, paving the way for more streamlined operations and stronger collaboration between the two Qatari entities. The planned facility is set to incorporate advanced salt production technologies, with the objective of meeting rising demand in the region and contributing to Qatar's ongoing efforts toward industrial diversification. QAPCO will continue to serve as the project development manager, providing all necessary support throughout the various phases of the project. MPHC has stated that further updates will be provided in due course, particularly as the project approaches the Final Investment Decision (FID) stage. Once completed, the cutting-edge salt production facility is expected to play a pivotal role in supporting key industrial sectors in Qatar and boosting the nation's manufacturing capabilities.
Scroll.in
28-05-2025
- Business
- Scroll.in
MPHC Class IV registration window closes today; apply now at mphc.gov.in
Today, May 28, is the last date to apply for the various Group D positions, including Liftman and Driver posts across its principal and bench locations through Madhya Pradesh High Court (MPHC) official website In case of any errors in the submitted application, a correction window will be available from May 29 to June 1, 2025. The schedule for interviews will be announced separately at a later date. More details in the notification below: Direct link to the notification. Application Fee The applicants from unreserved category are required to pay a fee of Rs 200, whereas Rs 100 applies to the reserved/EWS category candidates. Step to apply for Class IV recruitment
